Plasma Folate, Vitamin B12, and Homocysteine and Cancers of the Esophagus, Stomach, and Liver in a Chinese Population

REFERENCES

• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al.: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359–E386, 2015.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al.: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase no 11. Lyon, France: International Agency for Research on Cancer, 2013.
   Google Scholar
• Duthie SJ: Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 34, 101–109, 2011.
   PubMed Web of Science ®Google Scholar
• Crider KS, Bailey LB, and Berry RJ: Folic acid food fortification—its history, effect, concerns, and future directions. Nutrients 3, 370–384, 2011.
   PubMed Web of Science ®Google Scholar
• Food Fortification Initiative. http://www.ffinetwork.org/global_progress/index.php. Accessed on 12/18/2014.
   Google Scholar
• Kennedy DA, Stern SJ, Moretti M, Matok I, Sarkar M, et al.: Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol 35, 2–10, 2011.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Giovannucci E, and Wolk A: Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131, 1271–1283, 2006.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Giovannucci E, and Wolk A. Folate and risk of breast cancer: a meta-analysis. Journal of the National Cancer Institute 99, 64–76, 2007.
   PubMed Web of Science ®Google Scholar
• Hirsch S, Sanchez H, Albala C, de la Maza MP, Barrera G, et al.: Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol 21, 436–439, 2009.
   PubMed Web of Science ®Google Scholar
• Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, et al.: A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 16, 1325–1329, 2007.
   PubMed Web of Science ®Google Scholar
• World Cancer Research Fund/American Institute for Cancer Research: Cancers. In: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Researc, 2007, 244–318.
   Google Scholar
• Liu YX, Wang B, Wan MH, Tang WF, Huang FK, et al.: Meta-analysis of the relationship between the Metholenetetrahydrofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer. Asian Pac J Cancer Prev 12, 247–252, 2011.
   PubMed Web of Science ®Google Scholar
• Persson EC, Schwartz LM, Park Y, Trabert B, Hollenbeck AR, et al.: Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality. Cancer Epidemiol Biomarkers Prev 22, 415–421, 2013.
   PubMed Web of Science ®Google Scholar
• Mu LN, Cao W, Zhang ZF, Cai L, Jiang QW, et al.: Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes & Control: CCC 18, 665–675, 2007.
   PubMed Web of Science ®Google Scholar
• Chen SY, Chen CJ, Tsai WY, Ahsan H, Liu TY, et al.: Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1. Nutr Cancer 38, 179–185, 2000.
   PubMed Web of Science ®Google Scholar
• Knol MJ, van der Tweel I, Grobbee DE, Numans ME, and Geerlings MI: Estimating interaction on an additive scale between continuous determinants in a logistic regression model. International Journal of Epidemiology 36, 1111–1118, 2007.
   PubMed Web of Science ®Google Scholar
• Andersson T, Alfredsson L, Källberg H, Zdravkovic S, and Ahlbom A: Calculating measures of biological interaction. European Journal of Epidemiology 20, 575–579, 2005.
   PubMed Web of Science ®Google Scholar
• Hosmer DW and Lemeshow S: Confidence interval estimation of interaction. Epidemiology 3, 452–456, 1992.
   PubMed Web of Science ®Google Scholar
• Pfeiffer CM, Hughes JP, Durazo-Arvizu RA, Lacher DA, Sempos CT, et al.: Changes in measurement procedure from a radioassay to a microbiologic assay necessitate adjustment of serum and RBC folate concentrations in the U.S. population from the NHANES 1988–2010. The Journal of Nutrition 142, 894–900, 2012.
   PubMed Web of Science ®Google Scholar
• Wu MY, Kuo CS, Lin CY, Lu CL, and Syu Huang RF: Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study. Br J Nutr 102, 715–721, 2009.
   PubMed Web of Science ®Google Scholar
• Henning SM and Swendseid ME: The role of folate, choline, and methionine in carcinogenesis induced by methyl-deficient diets. Advances in Experimental Medicine and Biology 399, 143–155, 1996.
   PubMedGoogle Scholar
• Pogribny IP, James SJ, and Beland FA: Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency. Molecular Nutrition & Food Research 56, 116–125, 2012.
   PubMed Web of Science ®Google Scholar
• Das PM and Singal R: DNA methylation and cancer. J Clin Oncol 22, 4632–4642, 2004.
   PubMed Web of Science ®Google Scholar
• Pogribny IP, Ross SA, Wise C, Pogribna M, Jones EA, et al.: Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutation Research 593, 80–87, 2006.
   PubMed Web of Science ®Google Scholar
• Shivapurkar N and Poirier LA: Tissue levels of S-adenosylmethionine and S-adenosylhomocysteine in rats fed methyl-deficient, amino acid-defined diets for one to five weeks. Carcinogenesis 4, 1051–1057, 1983.
   PubMed Web of Science ®Google Scholar
• Henning SM, McKee RW, and Swendseid ME: Hepatic content of S-adenosylmethionine, S-adenosylhomocysteine and glutathione in rats receiving treatments modulating methyl donor availability. The Journal of Nutrition 119, 1478–1482, 1989.
   PubMed Web of Science ®Google Scholar
• James SJ and Yin L: Diet-induced DNA damage and altered nucleotide metabolism in lymphocytes from methyl-donor-deficient rats. Carcinogenesis 10, 1209–1214, 1989.
   PubMed Web of Science ®Google Scholar
• Pogribny IP, Muskhelishvili L, Miller BJ, and James SJ: Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats. Carcinogenesis 18, 2071–2076, 1997.
   PubMed Web of Science ®Google Scholar
• Melnyk S, Pogribna M, Miller BJ, Basnakian AG, Pogribny IP, et al.: Uracil misincorporation, DNA strand breaks, and gene amplification are associated with tumorigenic cell transformation in folate deficient/repleted Chinese hamster ovary cells. Cancer Letters 146, 35–44, 1999.
   PubMed Web of Science ®Google Scholar
• James SJ, Pogribny IP, Pogribna M, Miller BJ, Jernigan S, et al.: Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. The Journal of Nutrition 133, 3740S–3747S, 2003.
   PubMed Web of Science ®Google Scholar
• Bhattacharya RK, Francis AR, and Shetty TK: Modifying role of dietary factors on the mutagenicity of aflatoxin B1: in vitro effect of vitamins. Mutation Research 188, 121–128, 1987.
   PubMed Web of Science ®Google Scholar
• Kuo CS, Lin CY, Wu MY, Lu CL, and Huang RF: Relationship between folate status and tumour progression in patients with hepatocellular carcinoma. The British Journal of Nutrition 100, 596–602, 2008.
   PubMed Web of Science ®Google Scholar
• Lin CC and Yin MC: B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer. Eur J Nutr 46, 293–299, 2007.
   PubMed Web of Science ®Google Scholar
• Kim YI: Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen 44, 10–25, 2004.
   PubMed Web of Science ®Google Scholar
• Kim YI: Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 51, 267–292, 2007.
   PubMed Web of Science ®Google Scholar
• Magnus EM: Folate activity in serum and red cells of patients with cancer. Cancer Res 27, 490–497, 1967.
   PubMed Web of Science ®Google Scholar
• Nixon DW, Heymsfield SB, Cohen AE, Kutner MH, Ansley J, et al.: Protein-calorie undernutrition in hospitalized cancer patients. Am J Med 68, 683–690, 1980.
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Migliavacca S, Scotti A, Bonalumi MG, Scarpa D, et al.: Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann Surg 196, 170–179, 1982.
   PubMed Web of Science ®Google Scholar
• Wu A, Chanarin I, Slavin G, and Levi AJ: Folate deficiency in the alcoholic—its relationship to clinical and haematological abnormalities, liver disease and folate stores. British Journal of Haematology 29, 469–478, 1975.
   PubMed Web of Science ®Google Scholar
• Brunaud L, Alberto JM, Ayav A, Gerard P, Namour F, et al.: Effects of vitamin B12 and folate deficiencies on DNA methylation and carcinogenesis in rat liver. Clinical Chemistry and Laboratory Medicine: CCLM/FESCC 41, 1012–1019, 2003.
   PubMed Web of Science ®Google Scholar
• Chandar N and Lombardi B: Liver cell proliferation and incidence of hepatocellular carcinomas in rats fed consecutively a choline-devoid and a choline-supplemented diet. Carcinogenesis 9, 259–263, 1988.
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Sells MA, Reddy TV, and Lombardi B: Hepatocarcinogenic and promoting action of a choline-devoid diet in the rat. Cancer Research 45, 2834–2842, 1985.
   PubMed Web of Science ®Google Scholar
• Mikol YB, Hoover KL, Creasia D, and Poirier LA: Hepatocarcinogenesis in rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 4, 1619–1629, 1983.
   PubMed Web of Science ®Google Scholar
• Ghoshal AK and Farber E: The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis 5, 1367–1370, 1984.
   PubMed Web of Science ®Google Scholar
• Nakae D, Yoshiji H, Mizumoto Y, Horiguchi K, Shiraiwa K, et al.: High incidence of hepatocellular carcinomas induced by a choline deficient Lamino acid defined diet in rats. Cancer Research 52, 5042–5045, 1992.
   PubMed Web of Science ®Google Scholar
• Wainfan E and Poirier LA: Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Research 52, 2071S–2077S, 1992.
   PubMed Web of Science ®Google Scholar
• Hoover KL, Lynch PH, and Poirier LA: Profound postinitiation enhancement by short-term severe methionine, choline, vitamin B12, and folate deficiency of hepatocarcinogenesis in F344 rats given a single low-dose diethylnitrosamine injection. Journal of the National Cancer Institute 73, 1327–1336, 1984.
   PubMed Web of Science ®Google Scholar
• Collin SM, Metcalfe C, Refsum H, Lewis SJ, Zuccolo L, et al.: Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiology, Biomarkers & Prevention 19, 1632–1642, 2010.
   PubMed Web of Science ®Google Scholar
• Johansson M, Relton C, Ueland PM, Vollset SE, Midttun Ø, et al.: Serum B vitamin levels and risk of lung cancer. JAMA 303: 2377–2385, 2010.
   PubMed Web of Science ®Google Scholar
• Arendt JF, Pedersen L, Nexo E, and Sorensen HT: Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. Journal of the National Cancer Institute 105, 1799–1805, 2013.
   PubMed Web of Science ®Google Scholar
• Carmel R and Eisenberg L: Serum vitamin B12 and transcobalamin abnormalities in patients with cancer. Cancer 40, 1348–1353, 1977.
   PubMed Web of Science ®Google Scholar
• Fremont S, Champigneulle B, Gerard P, Felden F, Lambert D, et al. Blood transcobalamin levels in malignant hepatoma. Tumour Biol 12, 353–359, 1991.
   PubMed Web of Science ®Google Scholar
• Wakatsuki Y, Inada M, Kudo H, Oshio G, Masuda T, et al.: Immunological characterization and clinical implication of cobalamin binding protein in human gastric cancer. Cancer Research 49, 3122–3128, 1989.
   PubMed Web of Science ®Google Scholar
• Arendt JF and Nexo E: Unexpected high plasma cobalamin : proposal for a diagnostic strategy. Clinical Chemistry and Laboratory Medicine: CCLM/FESCC 51, 489–496, 2013.
   PubMed Web of Science ®Google Scholar
• Boisson F, Fremont S, Migeon C, Nodari F, Droesch S, et al.: Human haptocorrin in hepatocellular carcinoma. Cancer Detect Prev 23, 89–96, 1999.
   PubMedGoogle Scholar
• Ermens AA, Vlasveld LT, and Lindemans J: Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 36, 585–590, 2003.
   PubMed Web of Science ®Google Scholar
• Chiche L, Jean R, Romain F, Roux F, Thomas G, et al.: Clinical implications of high cobalamin blood levels for internal medicine. La Revue de medecine interne/fondee par la Societe nationale francaise de medecine interne 29, 187–194, 2008.
   PubMed Web of Science ®Google Scholar
• Lajous M, Lazcano-Ponce E, Hernandez-Avila M, Willett W, and Romieu I: Folate, vitamin B(6), and vitamin B(12) intake and the risk of breast cancer among Mexican women. Cancer Epidemiology, Biomarkers & Prevention 15, 443–448, 2006.
   PubMed Web of Science ®Google Scholar